References
- Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al.
Global and regional mortality from 235 causes of death for 20 age
groups in 1990 and 2010: a systematic analysis for the Global Burden
of Disease Study 2010. Lancet 2012;380(9859):2095-128.
- Gentile A, Paget J, Bellei N, Torres JP, Vazquez C, Laguna-Torres VA,
et al. Influenza in Latin America: A report from the Global Influenza
Initiative (GII). Vaccine 2019;37(20):2670-8.
- Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al.
Hospitalized patients with 2009 H1N1 influenza in the United States,
April-June 2009. N Engl J Med 2009;361(20):1935-44.
- Dominguez-Cherit G, De la Torre A, Rishu A, Pinto R, Namendys-Silva
SA, Camacho-Ortiz A, et al. Influenza A (H1N1pdm09)-Related Critical
Illness and Mortality in Mexico and Canada, 2014. Crit Care Med
2016;44(10):1861-70.
- Meltzer MI, Patel A, Ajao A, Nystrom SV, Koonin LM. Estimates of the
demand for mechanical ventilation in the United States during an
influenza pandemic. Clin Infect Dis 2015;60 Suppl 1:S52-7.
- Oliveira EC, Marik PE, Colice G. Influenza pneumonia: a descriptive
study. Chest 2001;119(6):1717-23.
- Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hernandez G, et al.
An Index Combining Respiratory Rate and Oxygenation to Predict Outcome
of Nasal High-Flow Therapy. Am J Respir Crit Care Med
2019;199(11):1368-76.
- Karim HMR, Esquinas AM. Success or Failure of High-Flow Nasal Oxygen
Therapy: The ROX Index Is Good, but a Modified ROX Index May Be
Better. Am J Respir Crit Care Med 2019;200(1):116-7.
- Duan J, Han X, Bai L, Zhou L, Huang S. Assessment of heart rate,
acidosis, consciousness, oxygenation, and respiratory rate to predict
noninvasive ventilation failure in hypoxemic patients. Intensive Care
Med 2017;43(2):192-9.
- Chen L, Zhou F, Li H, Xing X, Han X, Wang Y, et al. Disease
characteristics and management of hospitalised adolescents and adults
with community-acquired pneumonia in China: a retrospective
multicentre survey. BMJ Open 2018;8(2):e018709.
- Collins JP, Campbell AP, Openo K, Farley MM, Cummings CN, Hill M, et
al. Outcomes of Immunocompromised Adults Hospitalized With
Laboratory-confirmed Influenza in the United States, 2011-2015. Clin
Infect Dis 2020;70(10):2121-30.
- Ferrer M, Esquinas A, Leon M, Gonzalez G, Alarcon A, Torres A.
Noninvasive ventilation in severe hypoxemic respiratory failure: a
randomized clinical trial. Am J Respir Crit Care Med
2003;168(12):1438-44.
- Katzen J, Kohn R, Houk JL, Ison MG. Early Oseltamivir After Hospital
Admission Is Associated With Shortened Hospitalization: A 5-Year
Analysis of Oseltamivir Timing and Clinical Outcomes. Clin Infect Dis
2019;69(1):52-8.
- Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al.
Community-Acquired Pneumonia Requiring Hospitalization among U.S.
Adults. N Engl J Med 2015;373(5):415-27.
- Cantan B, Luyt CE, Martin-Loeches I. Influenza Infections and Emergent
Viral Infections in Intensive Care Unit. Semin Respir Crit Care Med
2019;40(4):488-97.
- Martin-Loeches I, Sanchez-Corral A, Diaz E, Granada RM, Zaragoza R,
Villavicencio C, et al. Community-acquired respiratory coinfection in
critically ill patients with pandemic 2009 influenza A(H1N1) virus.
Chest 2011;139(3):555-62.
- Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, et al.
Populations at risk for severe or complicated influenza illness:
systematic review and meta-analysis. BMJ 2013;347:f5061.
- Chen X, Liu S, Goraya MU, Maarouf M, Huang S, Chen JL. Host Immune
Response to Influenza A Virus Infection. Front Immunol 2018;9:320.
- Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of the
immune system. Transpl Int 2009;22(11):1041-50.
- Shi SJ, Li H, Liu M, Liu YM, Zhou F, Liu B, et al. Mortality
prediction to hospitalized patients with influenza pneumonia: PO2
/FiO2 combined lymphocyte count is the answer. Clin Respir J
2017;11(3):352-60.
- Bellelli V, d’Ettorre G, Celani L, Borrazzo C, Ceccarelli G, Venditti
M. Clinical significance of lymphocytopenia in patients hospitalized
with pneumonia caused by influenza virus. Crit Care 2019;23(1):330.
- Boonnak K, Vogel L, Feldmann F, Feldmann H, Legge KL, Subbarao K.
Lymphopenia associated with highly virulent H5N1 virus infection due
to plasmacytoid dendritic cell-mediated apoptosis of T cells. J
Immunol 2014;192(12):5906-12.
- Smith PK, Wang SZ, Dowling KD, Forsyth KD. Leucocyte populations in
respiratory syncytial virus-induced bronchiolitis. J Paediatr Child
Health 2001;37(2):146-51.
- Zhou Y, Fu X, Liu X, Huang C, Tian G, Ding C, et al. Use of
corticosteroids in influenza-associated acute respiratory distress
syndrome and severe pneumonia: a systemic review and meta-analysis.
Sci Rep 2020;10(1):3044.
- Hui DS, Lee N, Chan PK, Beigel JH. The role of adjuvant
immunomodulatory agents for treatment of severe influenza. Antiviral
Res 2018;150:202-16.
- Herfst S, van den Brand JM, Schrauwen EJ, de Wit E, Munster VJ, van
Amerongen G, et al. Pandemic 2009 H1N1 influenza virus causes diffuse
alveolar damage in cynomolgus macaques. Vet Pathol 2010;47(6):1040-7.
- Kraut JA, Madias NE. Treatment of acute metabolic acidosis: a
pathophysiologic approach. Nat Rev Nephrol 2012;8(10):589-601.
- Tobin MJ, Laghi F, Jubran A. Ventilatory failure, ventilator support,
and ventilator weaning. Compr Physiol 2012;2(4):2871-921.
- Davidson S. Treating Influenza Infection, From Now and Into the
Future. Front Immunol 2018;9:1946.
- Chen L, Han X, Li YL, Zhang C, Xing X. The impact of early
neuraminidase inhibitor therapy on clinical outcomes in patients
hospitalised with influenza A-related pneumonia: a multicenter,
retrospective study. BMC Infect Dis 2020;20(1):628.
- Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Lim WS, Al Mamun
A, et al. Impact of neuraminidase inhibitors on influenza
A(H1N1)pdm09-related pneumonia: an individual participant data
meta-analysis. Influenza Other Respir Viruses 2016;10(3):192-204.